Formulation design
Carrier system, sensory profile and cooling intensity built around your target format and price point.
Formulation R&D · PhD-led
Build the product without building a lab.
Our formulation team turns a brief into a testable prototype, then into a specification a factory can run. Development is scoped and priced before work starts.
Stability & compatibility
How the formula behaves over time, in its packaging, and against the other ingredients you want to use.
Scale-up ready
A specification written for production, so the bench sample repeats at pilot and at scale.
Which page do you need? This one covers the service — how a project is scoped, priced, developed and handed to production. The molecular data, in-vitro results and use-level guidance live on Technology; TDS, SDS and CoA requests go through the sample and document route.
The team
A doctorate-level team, accessible to startups.
Most contract labs are priced for companies that already have a development budget. We work the other way round: a modest, fixed development fee, and a route to offset it once you buy ingredient at scale.
- Project scoped and quoted before any bench work
- Revisions and milestones agreed in writing
- Qualifying fees creditable against later ingredient purchases
Credit thresholds, period and amount are set out in the signed agreement.
The molecule, not just the blend
Esterification route, purification and the move from bench quantity to one metric ton a month. Residual free menthol and by-product limits are set by the specification, not by the batch.
The system around it
Carrier, solubilisation, pH window, preservation and packaging compatibility — the four places a cooling ingredient usually dies before it reaches a shelf.
The numbers and the mouth
Routine identity and assay checks, stability sampling, and sensory panels that score onset, peak and duration separately.
Image note: laboratory and personnel visuals are illustrative renderings; team credentials are evidenced in writing during supplier qualification.
Scope
What a development project covers.
| Brief | Format, target market, price point, claims and packaging direction |
|---|---|
| Prototype | Bench samples for sensory evaluation, with documented trials |
| Iteration | Agreed revision rounds against your feedback |
| Stability | Testing plan appropriate to the format and destination market |
| Specification | Written specification and process notes for production |
| Handover | Formula reference, acceptance criteria and ownership per agreement |
| Production | Optional — manufactured through qualified partner factories |
Testing is scoped per project. Clinical, efficacy and market-authorisation files are quoted separately, with the underlying reports handed to you.
Who pays for what
The split that decides whether a project is affordable.
A development budget usually dies in the same place: the quotation arrives carrying twelve tests nobody scoped. Here is the whole list, before you have to ask for it.
| Stage | Who does it | Who pays | What you end up holding |
|---|---|---|---|
| Brief and feasibility call | Us | Nothing | A written go / no-go with the reasoning |
| Bench prototype | Us | Fixed project fee | Samples and a trial record |
| Formula lock and specification | Us | Fixed fee, creditable later | Controlled specification and process notes |
| Stability — real time and accelerated | Us, commissioned | At cost, passed through | Report for your file |
| Safety testing — irritation, ocular, sensitisation, oral where relevant | Third-party laboratory, commissioned by us | At cost, passed through | Report for your file |
| Market notification — CPNP, ACD, BPOM, FDA listing | You or your consultant | Your cost | Your registration |
| Halal or organic certification | Your certifier | Your cost | Your certificate |
| Ingredient purchase | Us | Per quotation | Material with CoA, SDS and specification |
The two “at cost” rows are quoted at the laboratory's price, with no management fee and nothing you did not scope.
Certification
The tests your market requires, bought once.
The arithmetic is simple. A CPNP dossier, an ACD notification in six countries, a US OTC monograph and a full OECD panel is a five-figure spend before the first kilo ships. Buying all of it up front loads every customer's price with paperwork most of them never use.
So we buy it per project instead: the panel your destination actually asks for, quoted at the laboratory's price, with the reports going into your file. Tell us the market and the timeline at the start, and the plan is built around it from day one.
| Test | Method | Why it is first |
|---|---|---|
| Skin irritation | OECD 439 (RhE) | Leave-on and baby-care briefs; the one a retailer will ask for |
| Eye irritation | OECD 492 (RhCE) | Sprays, wipes and anything applied near the face |
| Skin sensitisation | OECD 442C / 442E | Any leave-on product; menthol is a known sensitiser in free form |
| Acute oral toxicity | OECD 423 | Lip, oral-care and child-use formats — the study behind an oral-care claim |
| Ready biodegradability | OECD 301 | Retail sustainability questionnaires and some EU claims |
What the chemistry tells us: a simple mono-ester of two materials with long food and oral-care histories, no alcohol, no nanomaterials. That profile is why the basic toxicology panel is the first thing we quote for a new market — we commission it, and the report goes straight into your file.
Have a brief you can describe in a paragraph?
That is enough to start. We will tell you what is realistic and what it costs.